Long-term molecular follow-up in indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Durable molecular and clinical remiussion can be achieved only in follicular subtypes.

被引:0
|
作者
Corradini, P
Ladetto, M
Astolfi, M
Voena, C
Rizzo, E
Sametti, S
Benedetti, F
Vitolo, U
Caracciolo, D
Pileri, A
Tarella, C
机构
[1] Univ Milan, Ist Nazl Tumori, BMT Unit, Milan, Italy
[2] Univ Turin, Turin, Italy
[3] Hosp San Raffaele, Mol Hematol Lab, I-20132 Milan, Italy
[4] Univ Verona, I-37100 Verona, Italy
[5] Osped Molinette, Turin, Italy
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2849
引用
收藏
页码:681A / 681A
页数:1
相关论文
共 50 条
  • [1] Long-term follow-up of indolent lymphoma patients treated with high-dose sequential chemotherapy and autografting: Evidence that durable molecular and clinical remission frequently can be attained only in follicular subtypes
    Corradini, P
    Ladetto, M
    Zallio, F
    Astolfi, M
    Rizzo, E
    Sametti, S
    Cuttica, A
    Rosato, R
    Farina, L
    Boccadoro, M
    Benedetti, F
    Pileri, A
    Tarella, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) : 1460 - 1468
  • [2] Long-term molecular follow-up in indolent lymphomas following high-dose chemotherapy and PBPC autografting: durable molecular and clinical remissions can be achieved in follicular subtypes
    Corradini, P
    Ladetto, M
    Astolfi, A
    Voena, C
    Villa, C
    Vitolo, U
    Benedetti, F
    Pileri, A
    Tarella, C
    LEUKEMIA, 2001, 15 (12) : 2014 - 2014
  • [3] Long-term molecular follow-up in indolent lymphomas treated with high-dose chemotherapy and autografting: durable clinical and molecular remissions can be attained in follicular subtype
    Corradini, P
    Ladetto, M
    Astolfi, M
    Rizzo, E
    Benedetti, F
    Vitolo, U
    Caracciolo, D
    Zallio, F
    Boccadoro, M
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2003, 31 : S122 - S122
  • [4] Long-term molecular follow-up in indolent lymphomas treated with HDS and PBPC autografting: durable molecular and clinical remissions can be achieved in follicular subtypes
    Corradini, P
    Ladetto, M
    Astolfi, M
    Caracciolo, D
    Voena, C
    Villa, C
    Rizzo, E
    Vitolo, U
    Benedetti, F
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 2001, 27 : S234 - S234
  • [5] Long-term clinical and molecular follow-up of follicular or transformed lymphoma patients following front-line high-dose sequential (HDS) chemotherapy.
    Tarella, C
    Corradini, P
    Caracciolo, D
    Gavarotti, P
    Bianchi, A
    Astolfi, M
    Zaglio, F
    Pileri, A
    BLOOD, 1997, 90 (10) : 501 - 501
  • [6] High-dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: Long-term clinical and molecular follow-up
    Apostolidis, J
    Gupta, RK
    Grenzelias, D
    Johnson, PWM
    Pappa, VI
    Summers, KE
    Salam, A
    Adams, K
    Norton, AJ
    Amess, JAL
    Matthews, J
    Bradburn, M
    Lister, TA
    Rohatiner, AZS
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (03) : 527 - 536
  • [7] Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft
    C Tarella
    D Caracciolo
    P Corradini
    F Zallio
    M Ladetto
    A Cuttica
    G Rossi
    D Novero
    P Gavarotti
    A Pileri
    Leukemia, 2000, 14 : 740 - 747
  • [8] Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high-dose sequential chemotherapy and autograft
    Tarella, C
    Caracciolo, D
    Corradini, P
    Zallio, F
    Ladetto, M
    Cuttica, A
    Rossi, G
    Novero, D
    Gavarotti, P
    Pileri, A
    LEUKEMIA, 2000, 14 (04) : 740 - 747
  • [9] High-dose chemotherapy and PBPC autografting in indolent lymphomas: Evaluation of minimal residual disease and molecular follow-up.
    Corradini, P
    Astolfi, M
    Caracciolo, D
    Bondesan, P
    Voena, C
    Vitolo, U
    Cinque, F
    Pileri, A
    Tarella, C
    BONE MARROW TRANSPLANTATION, 1998, 21 : S183 - S183
  • [10] High-dose (HDS) chemotherapy and PBPO autografting in follicular and mantle cell lymphomas: Analysis of minimal residual disease and molecular follow-up
    Corradini, P
    Astolfi, M
    Caracciolo, D
    Bondesan, P
    Cherasco, C
    Pileri, A
    Tarella, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 1383 - 1383